Ruzanna Papyan on Neuroblastoma Risk Stratification in Real-World Settings
Ruzanna Papyan, Chief of Pediatric Oncology Department at PCBDC, Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia, shared on LinkedIn:
”Check out our new article, “Adaptive Clinical Neuroblastoma Risk Groups—Tailoring Treatment in Low- and Middle-Income Countries,” that has just been just published!
This work reflects a truly international collaboration and a shared commitment to adapting neuroblastoma risk stratification to real-world settings.
Read the article here.
Grateful for the collaboration, the shared vision, and the ongoing efforts to improve outcomes for children with neuroblastoma globally”
Article: Adaptive Clinical Neuroblastoma Risk Groups—Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project
Authors: Wendy London, Gabriela Villanueva, Derek Shyr, Jaques van Heerden, Soad Fuentes-Alabi, Raya Saab, Derek Harrison, Ruzanna Papyan, Hoa Thi Kim Nguyen, Dolly Noun, Joyce Kambugu, Jelena Rascon, Miklos Garami, Dongjing Guo, Paige Kao, Arlene Naranjo, Julie R. Park, Susan L. Cohn, Carlos Rodriguez-Galindo, Katherine K. Matthay
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 22, 2026, 11:27Prashasti Dahiya: Key Molecular Insights on Thromboinflammation and Angiogenesis in Pediatric Cancer
-
Apr 22, 2026, 11:17Jack Hadfield: Understanding the Immune and Genetic Basis of VITT Post-COVID Vaccines
-
Apr 22, 2026, 07:56Shruti Kharat: Closing the Gap in Early Detection of Factor VIII Inhibitors
-
Apr 22, 2026, 07:46Gregory Piazza: Ushering in a New Era in PE Therapy and Improved Clinical Outcomes for Our Patients
-
Apr 22, 2026, 07:40Akshat Jain: WIL33 Study Advances Factor Prophylaxis in Children with von Willebrand Disease
-
Apr 22, 2026, 07:36Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar 61
-
Apr 22, 2026, 07:34Aikati Anastasiou: Advancing Stroke Imaging Insights from the DISTAL Trial
-
Apr 22, 2026, 07:26Maxime Dely: How Do We Balance Benefit and Risk in Chronic Hematologic Diseases?
-
Apr 22, 2026, 07:19Sarah Richardson: Bringing Insights from HFA Symposium Back to Real Life